✦ LIBER ✦
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
✍ Scribed by Andrew J. Stewart Coats; Venkatesan Srinivasan; Jayaraman Surendran; Haritha Chiramana; Shankar R. K. G. Vangipuram; Nirajkumar N. Bhatt; Minish Jain; Sandip Shah; Irfhan A. B. H. Ali; Ho G. Fuang; Mohammed Z. M. Hassan; John Beadle; Julia Tilson; Bridget-Anne Kirwan; Stefan D. Anker; on behalf of the ACT-ONE Trial Investigators
- Book ID
- 107703879
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 177 KB
- Volume
- 2
- Category
- Article
- ISSN
- 2190-5991
No coin nor oath required. For personal study only.